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Take-Home Message 
The use of antimicrobial agents as growth promoters in animal production has been a relatively 
common practice since early 50's. With time, there was (and still is) a growing concern that the 
rate of antibiotic-resistant bacteria would be greater than the rate at which new effective 
antibiotics are developed. Based on the evidence collected and pressure from public opinion 
and human health organizations, the EU passed a total ban on antibiotics as growth promoters 
on January 1st, 2006. The consequences of the ban were: 1) an initial decrease in animal 
performance (that has later being partially improved), 2) an initial increased use of antibiotics for 
therapeutic purposes in animal husbandry, 3) the appearance of a wide range of compounds 
that claim to be alternatives to antimicrobials, 4) a change in production systems and nutrition, 
and 5) an improved public perception about animal production. The consequences on animal 
performance were most drastic in piglets than in other species. But, overall public perception of 
animal production improved greatly. Since then, a vast array of alternative additives has been 
proposed, all with variable degrees of success. Finding replacements for feed antibiotics will 
likely involve the use of multiple products in the diet as well as management and nutrition 
changes. Among the many additives proposed as alternative to antibiotics organic acids and 
pre- and probiotics are showing the greatest promise. 
Introduction 
The growth promoter effect of antibiotics was discovered in the 1940s, when it was observed 
that animals fed dried mycelia of Streptomyces aureofaciens containing chlortetracycline 
residues improved growth performance. The mechanism of action of antibiotics as growth 
promoters is related to interactions with intestinal microbial population (Niewold, 2007). Early 
work (Coates et al., 1995) showed that administration of antibiotic growth promoters to germ-
free animals had no effects. An additional mechanism that has been suggested is the 
improvement of nutrient digestibility through a reduction of gut wall and villus lamina propria 
(Anderson et al., 1999), although most of their effects are attributed to interactions with the gut 
microbiota (Dibner and Richards, 2005). 
Addition of chloratetracycline, sulfamethazine, virginamycin, and tilmicosin to treat enteritis, 
coccidiosis, and bovine respiratory disease in the ration of cattle arriving at the feedlot was also 
reported to improve growth rate, dry matter intake, and feed conversion while decreasing the 
risk of bovine respiratory disease and incidence of liver abscesses (Galyean et al., 1995; 
Salinas-Chavira et al., 2009). Whether this is a direct effect of antibiotics on performance or a 
result of improved health status of the animals is unknown, but there is consistent evidence that 
bovine respiratory disease has a direct negative effect on growth both short- (Bach et al., 2011; 
Stanton et al., 2012) and long- (Bach, 2011) term. 
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Furthermore, coccidiostats, such as ionophores, were commonly used (and approved) for 
poultry in the 1940's. It was noted that cattle grazing these pastures grew more rapidly than 
cattle grazing pastures fertilized with manure from chickens that were not fed monensin 
(Brodway et al., 2014). As a result, ionophores (i.e., monensin) were directly incorporated into 
cattle rations in the early 1970's; a practice that continues today. Also, in the US, rations for 
feedlot cattle are typically supplemented with monensin and tylosin. The mode of action of 
ionophores consists of direct inhibition of Gram positive bacteria such as non-desired rumen 
bacteria as lactic acid bacteria and hyperammonia producing bacteria. lonophores have been 
reported to reduce liver abscesses by inhibiting epithelial keratinization caused by rumen lactic 
acidosis and subsequent Fusobacterium necrophorum infections (Lechtenberg et al., 1998; 
Nagaraja and Chengappa, 1998), and have also been reported to increase growth performance 
through a variety of modifications of the ruminal microbial population (Callaway et al., 2003). 
Furthermore, ionophores have been described to increase energy and protein utilization in the 
rumen, and to improving production efficiency of dairy animals (Sprott et al., 1988; Duffield et 
al., 2008a,b,c). 
In dairy production systems, young calves fed milk replacer still receive antibiotics on a routine 
and continual basis. A US study reported that 63% of dairy calves were fed milk replacer, and 
that in 1990 to 1991, nearly 60% of milk replacers fed to dairy calves less than 3 weeks of age 
were medicated (Heinrichs et al., 1995). Antibiotic use was even greater from 3 weeks to 
weaning, as 71 % of milk replacers contained medication (Heinrichs et al., 1995). However, 
usage was reduced to 56% in 2001 (USDA, 2002), and this figure seems to have stabilized 
around 58% since then (USDA, 2010). Berge et al. (2005) concluded that removal of antibiotics 
from milk replacers may have a significant negative impact on calf health in the absence of 
adequate passive transfer; thus if antibiotics should be removed, adequate colostrum feeding 
practices and a clean and dry environment for calves is mandatory. 
However, the inclusion of antibiotics (including monensin) in animal feeds is receiving increased 
criticism because of the potential for antibiotic residues and resistant strains of bacteria (Russell 
and Mantovani, 2002; Oliver et al., 2011 ). For example avoparcin, a glycopeptide antibiotic not 
used in humans but included in some feeds as a growth enhancer, has been known to be 
associated with emergence of avoparcin-resistant strains, which are cross-tolerant to 
vancomycin, a glycopeptide antibiotic used in humans (Marshall and Levy, 2011 ). 
Antibiotic-resistant bacteria represent a potential risk for humans and for this reason, the World 
Health Organization (1997) and the Economic and Social Committee of the European Union 
(1998) concluded that the use of antimicrobials in animal feed was a public health issue. 
Sweden was the first EU country that discontinued the use of selected antibiotics as growth 
promoters in 1986, and Denmark withdrew avoparcin followed by the rest of the European 
Union in 1995. In 1999, the growth-promoting use of bacitracin, spiramycin, tylosin, and 
virginiamycin had ceased in Europe even though the EU Council stated that evidence of actual 
risk to human health was not forthcoming (EU Council, 1998). 
Therefore, recent efforts have been made to identify alternatives to antibiotics that can increase 
production efficiency of livestock. This article will review the potential problems related to feed 
antibiotics to ruminants, the consequences of the EU ban in animal production, and the potential 
advantages of alternative additives for ruminant production. 
The origin of the "resistance" 
Two conditions are needed for antibiotic resistance to first develop in bacteria. First, the 
organism must come into contact with the antibiotic. Then, resistance against the agent must 
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develop, along with a mechanism to transfer the resistance to next generations or to other 
bacteria. Each antibiotic operates at a specific site of the bacteria. For example, some target the 
cell walls (i.e., bacitracin, and penicillin), whereas others target cell membranes (i.e., 
ionophores ), cell protein synthesis (i.e., aminoglycosides, chloramphenicol, and tetracycline), 
RNA (i.e., rifamycins), DNA (i.e., nalidixic acid and quinolones) (Levy, 1998). Thus, when 
resistant organisms arise, their resistance is specific to a particular antibiotic or antibiotics that 
share the mode of action (Khachatourians, 1998). Four basic mechanisms of resistance have 
been documented: 1) development of mechanisms that prevent antimicrobial access to the site 
of action by increasing efflux or decreasing influx through the cell membrane; 2) development of 
enzymes that degrade or alter the antimicrobial agent; 3) alteration of the site of antimicrobial 
action, rendering the drug ineffective; and 4) development of site-of-action bypass mechanisms 
(Low, 2001 ). Genes encoding for these resistance can be chromosomal or extra-chromosomal. 
The extrachromosomal elements (plasmids and transposons) are small pieces of circular DNA 
and some can move from one bacterium to another irrespective whether or not antibiotics are 
present (Marshall et al., 1990). Unusual transfer of antibiotic-resistant DNA sequences between 
bacterial species and between different ecological niches (i.e., between humans and ruminants) 
have been documented (Khachatourians, 1998). However, most antibiotics used for treating 
infections are synthesized by microorganisms isolated from the environment, which suggests 
that genes for antibiotic resistance must also have emerged in non-clinical habitats (Martinez, 
2008). For example, multidrug resistance efflux pumps are present in all organisms and can 
exist in large numbers within a single microorganism (Lubelski et al., 2007). Thus, it must be 
acknowledged that previously unrecognized antibiotic resistance genes that may emerge in the 
future already exist in many, as yet ignored, environmental organisms (Martinez et al., 2007), 
and thus the feed antibiotics ban will not totally solve the bottom-line thread, although it may 
greatly contribute to minimize the risk as it has been shown that antibiotics in animal feed may 
facilitate phage-mediated gene transfer and thus promoting dissemination of antibiotic 
resistance (Allen et al., 2011 ). 
The consequences of the ban 
The complete ban of feed antibiotics in the EU has led to five main consequences: 1) an initial 
decrease in animal performance (that was later partially improved), 2) an initial increased use of 
non-feed antibiotics for therapeutic purposes in animal husbandry, 3) the appearance of a wide 
range of compounds that claim to be alternatives to antimicrobials, 4) a change in production 
systems and nutrition schemes, and 5) an improved public perception about animal production. 
The latter is of great importance as, after all, animal production should satisfy the nutritional 
needs of the consumer using acceptable means by the society. 
Early reports regarding the effects of the voluntary ban of feed-antibiotics in Denmark indicated 
that there was no effect on broiler productivity or longevity (Emborg et al., 2002), but feed 
efficiency decreased a 0.94% from November 1995 to May 1999 (from 56.2 to 55. 7% ), with feed 
efficiency reaching 54.6% immediately after the ban to a nadir lesser than 54.3% in late 1999 
(Emborg et al., 2002). Feed efficiency progressively improved after nutritional, management, 
and therapeutic measures were implemented. For instance, the use of salinomycin in 1996 was 
4,500 kg and 11,213 kg in 2002 (DANMAP, 2005), which probably reflects attempts by 
producers to use this drug to control necrotic enteritis since the feed antibiotic ban in Denmark 
in 1999 (Dibner and Richards, 2005). In swine, the effects of the ban were more evident, with a 
decline in average daily gain in piglets from 422 g in 1995 to 415 g/d in 2001 and an increase 
from 2.7 to 3.5% in mortality over the same period (Callesen, 2003). But, there has been no 
major effect of the feed antibiotic termination on productivity or feed efficiency in finishers 
(Middelbo, 2003). On the other hand, the ban seemed to have a beneficial impact on the 
91 
isolation of resistant bacteria from human stools (Figure 1 ), and this encouraged other EU 
countries to implement a similar ban. 
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Figure 1. Vancomycin-resistant Enterococcus (VRE) in stool culture samples from 
healthy humans in the community (The Netherlands and Germany) and in hospitalized 
patients (Belgium) following the European Union prohibition of the glycopeptide avoparcin 
as a growth promoter. Adapted from Wegener, 2003. 
As a result of the ban and a focus on disease prevention and conscious use of antimicrobials 
implemented in Sweden, the total use of antibiotics in farm animals decreased by approximately 
55% between 1986 and 1999, and a relatively low prevalence of antimicrobial resistance has 
been maintained since then Wierup (2001 ). In Denmark, as a consequence of the 
implementation of the voluntary antibiotic ban, the total use of antimicrobials decreased from 
about 200 tons in 1994 to 94 in 2001, but there was an increase of about 5% in the antibiotics 
used for therapeutic treatments of farm animal (DAN MAP, 2005). Similar trends have been 
observed in other EU countries. 
There are several reports indicating that the growth-promoter ban has driven an increase in 
infections and therefore an increase in the use of therapeutic antibiotics for livestock animals in 
Europe although the ban reduced the overall antibiotic use in animals (Figure 2). This increase 
in therapeutic use of antibiotics elicited a concern: whether an increase in antimicrobial 
resistance among Salmonella typhimurium and Campylobacter jejuni human isolates to 
tetracycline and other antimicrobials observed in Denmark in 2001 following the voluntary ban 
(Hayes and Jensen, 2003) was due to the increase in therapeutic use of antibiotics in farm 
animals (including tetracycline, aminoglycosides, macrolides and lincosamides which are also 
used human medicine). This concern was raised because antibiotics that were banned were 
active against Gram-negative bacteria and could not have created resistance in Gram-positive 
bacteria such as Salmonella or Campylobacter (Hayes and Jensen, 2003), but due to health 
problems that were encountered following the ban, many antimicrobials in use before the ban 
were replaced with tetracycline (which is active against Gram Positive bacteria). Tetracycline 
use in Denmark went from 12,100 kg in 1998 to 27,900 kg in 2001, and Denmark experienced 
problems with tetracycline resistance in humans. Similarly, the use of these compounds to treat 
infections caused by Enterobacter and Campylobacter in the Netherlands led to increases in the 
number of fluoroquinolone-resistant strains, which appeared in humans who consumed poultry 
(Endtz, 1991 ). The prevalence of enrofloxacin-resistant strains of Campylobacter in poultry and 
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humans increased from 0% to 14% and from 0% to 11 % respectively, and Koenaard et al. 
( 1995) reported a greater prevalence of quinolone-resistant Campylobacter isolates from 
s~wage plants receivi~g effluents from poultry processing plants. However, as time has passed 
since t_he b~n, pro~uct1on s~stems _have been progressively adapted with implementing 
reductions in stocking density and improvements in hygiene as well as nutritional changes that 
have allowed to reduce pathology and recover a large proportion of the performance lost when 
the feed antibiotics were initially removed. 
220 
200 -
ch 
180 -w 
C 
.-
5 160 -e 
~ 140 -
.Q 
0 
s.. 120 -
.:? 
E 
~ 100 -
.a: 
ao -
60 -
40 -r~ 
,:,.· 
20 - .~ 
0 
~ 0 
I 
-: 
' 
. I I I I 
~ 
.,;,-
DAA ft,,,\AP 20 04 
■ Mtimlcrobial gro\N'th promoters 
□ Pres cribed 1;aterlnaryanUmlcroblals 
D Prescribed human antibacteria ls 
I 
-
.~ :~ 
I 
-
" ~ ~,. ,~ 
a I-• 
, .. _ ~ 
-
f' r's 1, 
I-< it= : 
'' 
' 
' 
% V ~ .,,.. ~ ;...;> 12:ivl <2> l7 
Figure 2. Evolution of antibiotic use in farm animals in Denmark 
(Adapted from DANMAP, 2004). 
A European study conducted in 6 countries reported a significant decrease in the prevalence of 
E. faecium strains resistant to spiramycin and tylosin or to virginiamycin when comparing a 
period before and after the EU ban of these antibiotics (Bywater et al., 2005). However, there 
was no change in the resistance to glycopeptides (as expected as avoparcin use had already 
been discontinued earlier). Similarly, streptogramin resistance rates fell from 40 to 60% in the 
late 1990s to 16% in pigs and 13% in chickens in Denmark (DANMAP, 2005). The WHO (2003) 
concluded that the ban was successful in reducing the resistance gene pool, despite the fact 
that several macrolides, previously used both for growth promotion and for the prevention and 
treatment of infections, continued to be used legitimately for disease control, and their use for 
therapy increased after the ban (DANMAP, 2005). Thus, the main problem with the increased 
use of antibiotic for therapeutic use is that some of these antibiotics ( contrarily to the feed 
antibiotics) belong to the same families to those used in humans (and in occasions is the exact 
same antibiotic) and this practice might have posed a greater threat than that posed by feed 
antibiotics. For this reason, now in Europe there is an increasing concern, and likely an 
upcoming regulation, to limit, restrict, and define when and what type of antibiotic should be 
administered to livestock for therapeutic purposes. The concern originated mainly in The 
Netherlands, and was driven by the usage of antibiotics in livestock that are of critical 
importance for public health such as the fluoroquinolones and the 3rd and 4th generation 
cephalosporins. 
Lastly, for ruminants, a major drawback of the ban of feed antibiotics has been a drastic 
increase in the incidence of coccidia in young stock (both dairy and beef) due to the absence of 
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monensin in the grower feed. There have been several attempts to effectively decrease the 
incidence of this disease, but results have been either deceiving or not cost-effective. 
The alternatives 
Since the complete ban of feed antibiotics in 2006, in addition to changes in nutrition and 
management practices, a myriad of feed additives has been proposed as alternative. The 
proposed feed additives attempt to 1) improve digestibility, 2) control the intestinal flora, and 3) 
enhance the immune response. These three areas are basically covered by organic acids, 
enzymes, pre- and probiotics (or direct fed microbials), vaccines, and herbal compounds or 
plant extracts. Among these compounds, the most widely used at direct fed microbials, although 
recently, there has been an increase (probably transient) in the utilization of plant extracts. 
Organic acids 
Dicarboxylic acids (aspartate, fumarate and malate) are considered to be naturally occurring 
substances since they are major metabolic intermediates of the citric acid cycle and are 
therefore commonly found in plant and animal tissues. They are used as electron acceptors in 
the succinate-propionate pathway and so play a major role in ATP production in some rumen 
microbial cells. Supplementation of dicarboxylic acids such as aspartate, fumarate, and malate, 
stimulates the growth of S. ruminantium on lactate in the rumen (Martin and Streeter, 1995). 
Malate supplementation has been proposed to be effective in controlling rumen pH under in 
vitro conditions (Martin, 1998). Martin et al. (1999) reported an improvement in feed efficiency 
and animal growth when supplementing malate to finishing beef cattle consuming diets rich in 
rapidly available carbohydrates. The authors attributed these results to a reduction in subclinical 
rumen acidosis. Kung et al. (1982) reported that the addition of malate (140 g/d) increased milk 
persistency and VFA production. However, this level of supplementation is cost-prohibitive. 
Devant et al. (2007) used a lower and more practical dose (although still relatively expensive) of 
malate, and reported no differences in ruminal pH when supplementing dairy cattle with 80 g of 
malate per day during transition and early lactation. A potential more cost-effective alternative to 
the inclusion of malate in cattle rations could be the use of alfalfa or other forage varieties high 
in malate (Callaway et al., 2000). 
Enzymes 
The rumen ecosystem harbors about 1010 microorganisms/ml, and is composed of several 
hundred species (Edwards et al., 2004; Larue et al., 2005). These species possess a vast array 
of enzymes acting concertedly to degrade the plant substrates present in feeds. Some 
exogenous enzymes are resistant to ruminal degradation (Hristov et al., 1998) and may offer 
potential for improving diet digestibility and animal performance. The addition of exogenous 
amylase to the ration is one method of enhancing ruminal digestibility of both starch and 
nonstarch carbohydrates (Tricarico et al., 2008; Dilorenzo et al., 2010). 
Most studies conducted on exogenous enzymes have targeted dairy cattle, mainly due to the 
high passage rate of the digesta in lactating cows. Klingerman et al. (2009) reported that 
addition of exogenous amylase to a 25% starch diet increased milk yield and Gencoglu et al. 
(2010) reported that the addition of exogenous amylase to a 21 % starch diet increased apparent 
total-tract digestibilities of organic matter and fiber, decreased feed intake, and increased fat-, 
solids- and energy-corrected milk feed conversions; but Ferraretto et al. (2011) reported no 
advantages when adding amylase to 22% starch diets. Results of a more recent study indicated 
that amylase increased nutrient digestibility, but this did not translate into improved milk 
performance (McCarthy et al., 2013). Thus, the responses to exogenous enzymes in dairy cattle 
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seem variable and more research is needed to identify the diets where the advantage of these 
compounds can be most evident. Nevertheless, in a review of 20 experiments consisting of 41 
treatments, enzyme feed additives increased milk production an average of 1.2 kg/day 
(Beauchemin et al., 2003). This value is close to the 1.1 kg/day average milk production 
increase reported by Kung (1998) when summarizing 32 lactation studies supplementing direct-
fed microbials. 
Although there are fewer data, a positive response to supplementation of exogenous enzymes 
has been reported for in weight gain of growing beef cattle has (Beauchemin et al., 2001 and 
2004), as well as goats and sheep (Titi, 2003; Titi and Lubbadeh, 2004). 
Vaccines 
The use of hyperimmune sera (antibody vaccines) has also been proposed to minimize the 
incidence and/or severity of subacute rumen acidosis, and thus reduce or avoid the use of 
antibiotics for this purpose. However, antibodies are proteins and may not resist digestion or 
ruminant degradation. Nevertheless, Gill et al. (2000) reported that vaccination against S. bovis 
seemed effective in preventing rumen acidosis in sheep, but there is no evidence that it is 
effective in cattle, nor it has been commercialized. 
Herbal compounds 
Herbal compounds including essential oils (volatile oils obtained from plants, possessing the 
odor and other characteristic properties of the plant), herbs (plants with medical properties) and 
botanicals ( drugs made of a plant, as from roots, leaves, etc .. . ) have also been proposed as 
potential replacements for feed antibiotics. 
Flavonoids, have been proposed as an alternative to decrease pathogen shedding into the food 
supply (Holiman et al., 1996; Mandalari et al., 2007). Flavonoids have an antioxidant activity 
(Pietta, 2000) and have been reported to decrease the viability of pathogenic bacteria such as 
E. coli and Salmonella, as well as other microorganisms such as Candida albicans and 
Sacchromyces species (Friedman, 2007). 
Tannins (phenolic compounds that bind to proteins and other large molecules) have been used 
to slow the degradation rate of proteins in the rumen (Aerts et al. , 1999; Barry and McNabb, 
1999) and perhaps improve performance. Saponins are glycosides found in many plants that 
can alter the cell wall of Gram-positive bacteria such as Ruminococcus flavefaciens and 
Ruminocossus coccus a/bus without compromising the cellulolytic activity of Gram-negative 
such as Fibrobacter succinogenes (Wina et al., 2006). 
Several plant extracts, especially essential oils, have biologically active molecules with 
antimicrobial activities that protect plants from pathogens and herbivores. Essential oils are 
lipophilic, and thus interact with the cell membrane of bacteria, which accounts for their toxicity 
and antimicrobial effects, particularly against Gram positive bacteria. Several plant extracts, 
including garlic oil, cinnamaldehyde (from cinnamon), and eugenol (from cloves), have been 
reported to influence rumen fermentation in vitro (Calsamiglia et al., 2007), but evidence of their 
effectiveness in vivo is currently lacking, and doses used in vitro could not realistic be 
extrapolated to in vivo conditions (Gauthier, 2005). A few investigations have been conducted to 
determine the effect of various plant extracts on production performance of dairy cows. For 
example, feeding a blend of thymol, eugenol, vanillin, guaiacol, and limonene increased feed 
intake and fact-corrected milk of lactating dairy cows fed a moderate dose (600 mg/d; Kung et 
al., 2008); whereas at greater doses, it had no effect on intake or production although it 
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increased rumen pH either at 750 mg/d (Benchaar et al., 2007) or at 2 g/d (Benchaar et al., 
2006). However, in another study, in which dairy cows were fed an intermediate dose (1.2 g/d) 
of the same blend of plant extracts the authors reported a decrease in feed intake and no effect 
on milk production (Tassoul and Shaver, 2009). Supplementing a blend of eugenol, geranyl 
acetate, and coriander led to a decrease in feed intake but an increase in milk fat yield, 
indicating a potential shift in energy usage for milk fat synthesis (Santos et al., 2010). 
Supplementation of lactating dairy cows with a blend of cinnamaldehyde, thymol, and orange 
peel at 640 mg/d increased both the fat and protein contents of milk, but had no effect on feed 
intake or milk production (Spanghero et al., 2009), and a blend of cinnamaldehyde and eugenol 
fed at about 500 mg/d had no effect on intake or performance (Tager and Krause, 2011; 
Tekippe et al., 2013) an when fed at an extremely high dose (10 g/d) impaired rumen 
fermentation {Tager and Krause, 2011 ). 
A widespread use of plant extracts in the future as performance enhancers for ruminants seems 
to be limited due to 1) a high variability (and difficulty to assess it) in quality and quantity of the 
active compound in the feed (this variation is due in part to the fact that accumulation of 
secondary metabolites is greatly affected by environmental conditions and cultivar variety), 2) 
some of the bioactive compounds have antioxidant activity, and this property can be lost during 
storage (Jouany and Morgavi, 2007), and 3) inclusion rates depend on the chemical 
composition of the plant preparation (Cordell, 2000). In addition, essential oils are "generally 
recognized as safe" but they must be used cautiously because they can be toxic (allergens) and 
their odor/taste may result in feed refusal (Lis-Balchin, 2003). Furthermore, they are part of the 
defense mechanism used by plants against pathogens and herbivores and little information is 
available on the transfer of these substances into edible animal products and their possible 
toxicity for consumers (Jouany and Morgavi, 2007) .Currently, the EU is allowing the use of 
essential oils and other plant extracts as flavor enhancers and as such, do not require to be 
evaluated by European Food Safety Authority (EFSA) as effective in fostering improvements in 
animal production. This 'back door' has been used by the industry to position plant extracts in 
the market. 
Lastly, it is rather surprising that the EU banned monensin but currently allows the use 
compounds with potential antimicrobial activity such as essential oils with exact modes of 
actions (in some cases) to those of monensin. For example, a described mode of action for the 
essential oil carvacrol is the potassium efflux (Ultee et al., 1999), the same action mode as that 
of monensin ( currently banned in the EU). 
Direct-fed microbial 
lonophores, such as monensin, have been (and in many areas of world still are) included in 
ruminant diets to mitigate the negative consequences of acute rumen acidosis (Nagaraja et al., 
1987; Mutsvangwa et al., 2002). Similarly, the non-ionophore antibiotic tylosin is commonly 
used (also in some parts of the world) to reduce lactic acid production in the rumen (Nagaraja 
et al., 1987) and control the growth of Fusobacterium necrophorum (Lechtenberg et al., 1998), 
thought to be partly responsible for the occurrence of liver abscesses. In the EU, the control of 
acute rumen acidosis after the antibiotic ban has mainly relied on direct fed microbials (both 
bacteria and yeast). 
Bacteria 
Both, lactic acid producing bacteria and lactic acid utilizers have been proposed as potential 
alternatives to control rumen acidosis. For instance, supplementation of Enterococcus faecium 
have been reported to increase ruminal pH (Ghorbani et al., 2002; Nocek and Kautz, 2006) and 
96 
maintenance of an active lactate-utilizing population, such as Megasphaera elsdenii, in the 
rumen (Jouany and Morgavi, 2007; Nocek and Kautz, 2006). However, Raeth et al. (2007) 
supplemented lactating cows with Lactobacillus acidophilus and Propionibacteria freudenreichii 
and reported no effects on cow performance, diet digestibility, or rumen fermentation. 
In addition, it appears that the supplementation of Lactobacillus species may exert further 
benefits as a probiotic in the lower digestive tract (Brown and Nagaraja, 2009). On the other 
hand, lactic acid utilizers, such as Megasphaera elsdenii, have been reported to be effective in 
decreasing the accumulation of lactic acid in in vitro systems and avoiding the pH decline in 
both in vitro and in vivo (Hino et al., 1994; Wiryawan and Brooker, 1995). 
Lastly, there are several bacteria that produce bacteriocins. Bacteriocins are proteins that inhibit 
the growth of other bacteria and are synthesized by bacteria occupying the same environment 
(Jack et al., 1995). The presence of bacteriocins in the rumen has been reported by several 
authors (Wells et al., 1997; Russell and Mantovani, 2002), and some of the them, such as those 
produced by Lactococcus have the ability to inhibit the growth of E. coli O157:H7 (Peterson et 
al., 2007; Rozema et al., 2009). However, further research is needed to assess when these 
bacteriocins and produced and how to control them. 
Live yeast, yeast fermentation products, and yeast cell wall products 
In spite of the increasing number of studies on bacterial probiotics, by far the most commonly 
used probiotics in adult ruminants are based on yeast preparations of Aspergillus orizae and 
(or) Saccharomyces cerevisiae, with the latter, being the most commonly used. 
Yeasts are aerobic and cannot survive for long in an anaerobic environment such as the rumen. 
For this reason, they must be supplied continuously in feeds to reach the minimum effective 
concentration, set at 105 colony-forming units per gram of rumen content (Jouany and Morgavi, 
2007). Live yeast, in particular Saccharomyces cerevisiae has been proposed as a potential 
alternative to monensin. Yeasts seem particularly useful in high-producing ruminants whose 
digestive microbial balance can be altered by high-dietary energy input (Chaucherays-Durand et 
al., 2008). Some live yeasts have been described to stimulate rumen bacterial growth through 
the provision of growth factors (Callaway and Martin, 1997) as well as increased nutrient 
digestion (Wohlt et al., 1991 ). Direct comparisons between monensin and yeast are scarce. A 
recent study (Swyers et al., 2014) compared the use of monensin and Saccharomyces 
cerevisiae fermentation product in yearling beef steers and reported that that carcasses from 
yeast-supplemented animals were lighter, although a greater proportion of them were graded as 
USDA choice than animals that were supplemented with monensin. In dairy cattle, 
supplementation of live yeast has been reported to increase milk production and dry matter 
intake (Jouany, 2006; Sniffen et al., 2004; Stella et al., 2007). 
As live yeast can survive and remain metabolically active in the gut, they can exert probiotic 
effects by interacting with the autochthonous microbial species responsible for feed digestion 
(Chaucherays-Durand et al., 2008). Up to now, the most consistent positive effects of live yeast 
have been reported on rumen microbial activity in young ruminants, stabilization of rumen pH, 
and prevention of rumen acidosis, as well as stimulation of growth and activity of fiber-degrading 
bacteria (Chaucherays-Durand et al., 2008). The ability of life yeast to control lactic acid 
concentrations in the rumen has been reported in rumen-cannulated dairy cows (Williams et al, 
1991) and using in vitro incubations with mixed ruminal microorganisms (Lila et al., 2004). This 
effect could be explained by the fact that one strain of S. cerevisiae has been shown to 
outnumber S. bovis in the utilization of sugars, consequently limiting the amount of lactate 
produced in the rumen (Chaucheyras et al., 1996). Similar to observations made with 
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Enterococcus strains and A. oryzae, some species of yeast have been shown to stimulate the 
growth of a specific lactic acid-utilizing bacteria in the rumen such as Selenomonas ruminantium 
(Nisbet and Martin, 1991; Rossi et al., 2004 ), by supplying different growth factors including 
amino acids, peptides, vitamins, and organic acids. Bach et al. (2007) reported that 
supplementation of live dry yeast ( S. cerevisiae) increased the average rumen pH and average 
maximum pH by 0.5 units, and average minimum pH by 0.3 units in loose-housed lactating 
cows. Furthermore, the authors described a significant change in the eating behavior of-the 
animals. Cows supplemented with live yeast had a shorter inter-meal interval (3.32 h) than 
unsupplemented cows (4.32 h). It has been suggested that this change in feeding behavior 
could also be responsible for changes in rumen pH. A similar study by Thrune et al. (2009) from 
the University of Minnesota reported an increase in average rumen pH of 0.2 units when 
comparing live yeast-supplemented cows with unsupplemented cows kept in tie-stalls. 
Aspergillus oryzae is the most common fungus used as a probiotic. This fungus has been 
reported to improve fiber digestion in the rumen (Judkins and Stobart, 1988; Fondevilla et al., 
1990), but with no effects on rumen volatile fatty acid or ammonia N concentrations (Gomez-
Alarcon et al., 1990). Some strains of A oryzae have been reported to stimulate the growth of 
M. elsdenii (Waldrip and Martin, 1993) and Selenomonas ruminantium (Nisbet and Martin, 
1993), which both actively metabolize lactic acid into propionic acid, thus reducing the risk and 
severity of acidosis. However, positive effects of A. oryzae on modulating rumen pH have not 
been found in the literature. 
Yeast cell wall products are another type of feed supplement that have been fed to livestock as 
a means to improve animal performance and gut health by impeding some bacteria to attach to 
their target intestinal cells. Yeast cell wall components have been reported to function as 
immunomodulators that activate macrophages, neutrophils, and other immunocompetent cells 
(Onderdonk et al., 1992; Eicher et al., 2006;). Yeast cell wall products have also been shown to 
improve metabolism in heifers during an endotoxin immune challenge (Burdick Sanchez et al., 
2014). 
Fructo oligosaccharide inclusion in human diets appears to result in fecal bulking and selective 
stimulation of bifidabacterium growth in the colon (Van Loo et al., 1999). Mannan 
oligosaccharides contain cell wall fragments obtained from Saccharomyces cerevisiae. Mannan 
oligosaccharides have improved performance in nursery pigs (Dvorak and Jacques, 1998) and 
weight gain and feed intake in dairy calves (Dvorak and Jacques, 1997). Because many Gram 
negative bacteria attach to the intestinal epithelium using mannose-specific fimbriae (Ofek et al., 
1977), mannan oligosaccharides provide competitive binding sites for these intestinal 
pathogens. Feed intake has been reported to increase in mannan oligosaccharide-fed calves 
compared with antibiotic-fed calves, but this difference did not result in growth differences 
during the experimental period (Heinrichs et al., 2003). Although mannan oligosaccharides have 
been described to alter lymphocyte response in vitro (Muchmore et al., 1990), their effects on 
animal immune system are not well established. The supplementation of mannan 
oligosaccharides in the milk replacer stimulated starter intake after weaning, but this 
supplementation did not have a determining effect on reducing bacteria counts or 
Cryptosporidium spp. presence in calf feces, nor in rate of growth (Terre et al., 2007). 
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